Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Nymox Pharmaceutical Corp

+ Add to Watchlist

NYMX:US

0.3900 USD 0.0100 2.50%

As of 20:10:00 ET on 01/30/2015.

Snapshot for Nymox Pharmaceutical Corp (NYMX)

Open: 0.4000 Day's Range: 0.3900 - 0.4040 Volume: 246,534
Previous Close: 0.4000 52wk Range: 0.3311 - 5.9800 1-Yr Rtn: -93.26%

Stock Chart for NYMX

No chart data available.
  • NYMX:US 0.3900
  • 1D
  • 1M
  • 1Y
0.4000
Interactive NYMX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NYMX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1500
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 13.67
Shares Outstanding (M) 35.05
30 Day Average Volume 248,455
Price/Book (mrq) -
Price/Sale (ttm) 4.3143
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NYMX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NYMX

Nymox Pharmaceutical Corporation is a biopharmaceutical company. The Company is engaged in therapeutics in development for enlarged prostate (BPH), E. coli, Alzheimer's disease and other indications and diagnostics for tobacco exposure, Alzheimer's disease and other conditions.

Paul AverbackChairman/President/CEO/FounderAndre MonetteChief Financial Officer
Jack GemmellCIO/General CounselBrian DoyleSenior Mgr:Global Sales & Mktg
More Company Profile & Key Executives for NYMX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil